Condition: Primary Aldosteronism · Sponsor: China National Center for Cardiovascular Diseases
This study aims to establish the screening and diagnostic cut-off points for primary aldosteronism patients by a novel small molecule "sandwich method" aldosterone and renin chemiluminescent immunoassay.
This description comes directly from the study's public registry record.
Jun Cai · caijun7879@126.com
Zhou Zhou · +86 10 88398055 · zhouzhou@fuwaihospital.org
Always discuss trial participation with your own doctor first.
| Kai-juan Wang | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06571084